Clinical Trial Update: Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating supplementation with Galatonol 300 mg and Striatin 30 mg in postpartum lactating mothers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactation Induced

Drugs mentioned

• Galatonol
• STRIATIN

Snippet

Sponsor: Dexa Medica Group | Conditions: Lactation Induced | Phase 3 | Status: COMPLETED